EXPstocktrader
EXPstocktrader
Send Message
EXPstocktrader
Stop FollowingEXPstocktrader
View as an RSS Feed
View EXPstocktrader's Articles BY TICKER:
- A VirnetX Short Squeeze May Be Setting Up
- Affymax Could Be The Best Reversal Play For 2013
- Microsoft's Skype Integration And VirnetX's Technology
- Is Apple Flip Flopping Over Heat From Its Enterprise Customers?
- Apple Says It Is Willing To Throw The Baby Out With The Bath Water Over Royalties
- Affymax: Swift Actions Seen On Former Biotech Darling
- Judge Upholds VirnetX Jury Verdict Against Apple For $368M
- Vringo: The Calm Before The Storm
- Upcoming Catalysts For Vivus
- The Judge Should Rule Favorably For Vringo On Motions
- As A Frustrated Owner Of Vringo Stock, What Should I Do?
- Vivus Rallies After Aetna Drug Policy Change
- SEC Busts A Ring Trading Top-Quality Med Stocks
- Vivus May Be A Real Value Play At These Levels
- Vringo Fires Another Shot Across ZTE's Bow
- Vringo Discusses Its Scalable Business Model On Q3 Results Conference Call
- Vringo And The Mystery Of Sealed Court Document 790
- Vringo's Court Win Suggests Running Royalties May Yield $500-$600 Million
- Caution: Stay On Alert With Numerous End Of Year Form 4's Being Filed By Insiders
- Vringo Receives Positive Patent News
- Questcor Pharmaceuticals - An Opportunity Following The Bear Raid?
- Complete Genomics: A Leader In DNA Sequencing
- Vivus Gets FDA Approval For Obesity Pill Qsymia
- Combination Drugs Used With Doxorubicin For The Treatment Of Various Cancers To Increase Efficacy
- Global Patent Wars Intensify In 2012
- Positive Data Released On Idenix Pharmaceuticals IDX184 Hep C Drug
- Vringo Receives Positive Overall Rulings
- Idenix Pharmaceuticals: A Hepatitis C Play Revisited
- Russell 3000 U.S. Healthcare Additions For June 2012
- Threshold's Management Presents At Jefferies Healthcare Conference (Notes)
- 2 Drug Combination Stocks Targeting Leukemia
- Threshold Pharmaceutical's TH-302 Could Be A Blockbuster By Targeting Hypoxia In Cancer
